
Introducing babyGLOW™ by Teoxane, a new innovation in skin revitalisation and HA skin booster treatments developed through a global consensus of aesthetic experts.
The technique uses a precise mapping system based on four anatomical landmark lines and eight safe injection points, creating a structured and easy-to-adopt treatment protocol for practitioners.

Performed with Teoxane’s Redensity 1 (3ml), Teoxane babyGLOW™ is designed to meet growing patient demand for treatments that deliver both an immediate glow and long-term improvements in skin quality.
This dual benefit is powered by Redensity 1’s unique formulation of high molecular weight, non-crosslinked hyaluronic acid, combined with the Dermo-Restructuring Complex – a carefully balanced blend of amino acids, antioxidants, minerals and vitamins that supports and revitalises the skin’s extracellular environment.
Dr Jeremy Isaac demonstrates the 8-point technique, mapping out the 4 landmark lines and each injection point on a patient, and how to inject Redensity 1 as part of the Teoxane babyGLOW™ technique.
Before & After images showcasing results of the Teoxane babyGLOW™ technique with Redensity 1.
.jpg?strip=true)
.jpg?strip=true)
Download your Teoxane babyGLOW™ How-To Guide and HCP Brochure to support seamless integration into your clinic.
The How-To Guide provides a clear overview of the Teoxane babyGLOW™ technique, including the clinical rationale behind each injection point and a visual guide to product placement.
The HCP Brochure explores the development of Teoxane babyGLOW™, featuring practitioner and patient testimonials, along with key information on Redensity 1.
A catalogue of assets collated for you to download and use to promote and educate consumers on the Teoxane babyGLOW™ technique and Redensity 1.
References:
1.Teoxane, Data on file collected from Patients Testimonials
2. Teoxane, Data on file collected from HCPs reports, Nov 17th 2025— Redensity 1 and the babyGlow Protocol for Beautification and Rejuvenation – A Case Series – Contouring with Light
3. Bezpalko L, Filipskiy A. Clinical and Ultrasound Evaluation of Skin Quality After Subdermal Injection of Two Non-Crosslinked Hyaluronic Acid-Based Fillers. Data on file. Document No. REF-00153. Clinical Hospital of Lviv Railway, Lviv, Ukraine; Danylo Halytsky Lviv National Medical University, Revive Aesthetic Medicine Clinic, Lviv, Ukraine. 4. Instructions for Use - Teosyal PureSense Redensity 1 (3ml)
5.Fanian F, et al. In vivo injection of oligonutrients and high molecular weight hyaluronic acid – results of a randomized controlled trial. Aesthetic Medicine. 2017; 3(4):23-34. 2.TEOSYAL® PureSense Redensity 1 study 10E2047 on human skin explants, conducted by BIO-EC.
* Teosyal Puresense Redensity 1